Furthermore, studies performed on NPC tumor biopsies or cell lines with enhanced invasiveness or epithelial-mesenchymal transitions also revealed enhanced expression of Sox2, Oct-4, and Nanog[63]–[66], similar to the findings reported here on CD24+ cells. The gene discussed is CD24; the disease is nasopharyngeal carcinoma.